Biodesix Receives $11,000,000 Series E Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8562ba6a-d0c6-4930-b85d-162f0484de75 - Date
6/24/2015 - Company Name
Biodesix - Mailing Address
2970 Wilderness Place Boulder, CO 80301 USA - Company Description
Biodesix was founded in 2005 to apply the principles of complex data analysis and mass spectrometry (MS) to the discovery and development of improved multivariate tests that give physicians better information to understand the patient and their disease. - Website
http://www.biodesix.com - Transaction Type
Venture Equity - Transaction Amount
$11,000,000 - Transaction Round
Series E - Proceeds Purposes
The investment will be used for ongoing new product development and expansion of commercial efforts to support Biodesix’ commercialized products, VeriStrat and GeneStrat, as well as new product launches in 2015 – 2016. - M&A Terms
- Venture Investor
